ESTRO 2025 - Abstract Book

S1335

Clinical - Lung

ESTRO 2025

Conclusion: For TET patients, the benefits of proton BH treatment depend on patient anatomy. 10 % of the analyzed patients show a large gain, which is important in view of the reduction of late side effects in patients with a long survival.

Keywords: Thymoma, breath hold, proton therapy

References: 1. Wijsman R, Dankers F, Troost EGC, et al. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo- )radiotherapy. Radiotherapy and Oncology . 2015;117(1):49-54. doi:10.1016/j.radonc.2015.08.010 2. Defraene G, Dankers FJWM, Price G, et al. Multifactorial risk factors for mortality after chemotherapy and radiotherapy for non-small cell lung cancer. Radiotherapy and Oncology . 2020;152:117-125. doi:10.1016/j.radonc.2019.09.005 3. Darby SC, Ewertz M, McGale P, et al. Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. N Engl J Med . 2013;368(11):987-998. doi:10.1056/NEJMoa1209825